Bakshi, H.A.; Quinn, G.A.; Aljabali, A.A.A.; Hakkim, F.L.; Farzand, R.; Nasef, M.M.; Abuglela, N.; Ansari, P.; Mishra, V.; Serrano-Aroca, Á.;
et al. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals 2021, 14, 1211.
https://doi.org/10.3390/ph14121211
AMA Style
Bakshi HA, Quinn GA, Aljabali AAA, Hakkim FL, Farzand R, Nasef MM, Abuglela N, Ansari P, Mishra V, Serrano-Aroca Á,
et al. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals. 2021; 14(12):1211.
https://doi.org/10.3390/ph14121211
Chicago/Turabian Style
Bakshi, Hamid A., Gerry A. Quinn, Alaa A. A. Aljabali, Faruck L. Hakkim, Rabia Farzand, Mohamed M. Nasef, Naji Abuglela, Prawej Ansari, Vijay Mishra, Ángel Serrano-Aroca,
and et al. 2021. "Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon" Pharmaceuticals 14, no. 12: 1211.
https://doi.org/10.3390/ph14121211
APA Style
Bakshi, H. A., Quinn, G. A., Aljabali, A. A. A., Hakkim, F. L., Farzand, R., Nasef, M. M., Abuglela, N., Ansari, P., Mishra, V., Serrano-Aroca, Á., & Tambuwala, M. M.
(2021). Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals, 14(12), 1211.
https://doi.org/10.3390/ph14121211